nodes	percent_of_prediction	percent_of_DWPC	metapath
Cytarabine—POLD1—uterine cancer	0.582	1	CbGaD
Cytarabine—ABCC10—Etoposide—uterine cancer	0.0713	0.282	CbGbCtD
Cytarabine—SLC22A2—Progesterone—uterine cancer	0.0557	0.22	CbGbCtD
Cytarabine—ABCC10—Doxorubicin—uterine cancer	0.0486	0.192	CbGbCtD
Cytarabine—SLC22A1—Progesterone—uterine cancer	0.0484	0.191	CbGbCtD
Cytarabine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0134	0.053	CbGbCtD
Cytarabine—CYP3A4—Progesterone—uterine cancer	0.00889	0.0351	CbGbCtD
Cytarabine—POLD1—oviduct—uterine cancer	0.00461	0.0651	CbGeAlD
Cytarabine—CYP3A4—Etoposide—uterine cancer	0.00398	0.0157	CbGbCtD
Cytarabine—CYP3A4—Doxorubicin—uterine cancer	0.00271	0.0107	CbGbCtD
Cytarabine—POLD1—exocrine gland—uterine cancer	0.00266	0.0376	CbGeAlD
Cytarabine—Gemcitabine—POLD1—uterine cancer	0.00199	0.545	CrCbGaD
Cytarabine—DCTD—myometrium—uterine cancer	0.00146	0.0205	CbGeAlD
Cytarabine—POLB—uterine cervix—uterine cancer	0.00141	0.0198	CbGeAlD
Cytarabine—POLB—decidua—uterine cancer	0.00134	0.0189	CbGeAlD
Cytarabine—POLD1—uterine cervix—uterine cancer	0.00115	0.0162	CbGeAlD
Cytarabine—DCTD—uterine cervix—uterine cancer	0.00113	0.016	CbGeAlD
Cytarabine—NT5E—myometrium—uterine cancer	0.00113	0.0159	CbGeAlD
Cytarabine—POLE—myometrium—uterine cancer	0.0011	0.0156	CbGeAlD
Cytarabine—DCTD—smooth muscle tissue—uterine cancer	0.0011	0.0155	CbGeAlD
Cytarabine—DCTD—decidua—uterine cancer	0.00108	0.0152	CbGeAlD
Cytarabine—POLD1—renal system—uterine cancer	0.00107	0.0152	CbGeAlD
Cytarabine—DCTD—renal system—uterine cancer	0.00106	0.015	CbGeAlD
Cytarabine—POLB—female reproductive system—uterine cancer	0.00105	0.0149	CbGeAlD
Cytarabine—CDA—uterine cervix—uterine cancer	0.00103	0.0145	CbGeAlD
Cytarabine—DCTD—endometrium—uterine cancer	0.00102	0.0145	CbGeAlD
Cytarabine—DCTD—mammalian vulva—uterine cancer	0.000991	0.014	CbGeAlD
Cytarabine—CDA—decidua—uterine cancer	0.000982	0.0139	CbGeAlD
Cytarabine—POLB—female gonad—uterine cancer	0.000958	0.0135	CbGeAlD
Cytarabine—POLD1—uterus—uterine cancer	0.000957	0.0135	CbGeAlD
Cytarabine—POLB—vagina—uterine cancer	0.000952	0.0134	CbGeAlD
Cytarabine—POLA1—myometrium—uterine cancer	0.000951	0.0134	CbGeAlD
Cytarabine—DCTD—uterus—uterine cancer	0.000944	0.0133	CbGeAlD
Cytarabine—CDA—endometrium—uterine cancer	0.000932	0.0132	CbGeAlD
Cytarabine—CDA—mammalian vulva—uterine cancer	0.000902	0.0127	CbGeAlD
Cytarabine—NT5E—epithelium—uterine cancer	0.000884	0.0125	CbGeAlD
Cytarabine—NT5E—uterine cervix—uterine cancer	0.000876	0.0124	CbGeAlD
Cytarabine—Clofarabine—RRM2—uterine cancer	0.000865	0.237	CrCbGaD
Cytarabine—POLD1—female reproductive system—uterine cancer	0.00086	0.0121	CbGeAlD
Cytarabine—POLE—uterine cervix—uterine cancer	0.000859	0.0121	CbGeAlD
Cytarabine—NT5E—smooth muscle tissue—uterine cancer	0.000852	0.012	CbGeAlD
Cytarabine—DCTD—female reproductive system—uterine cancer	0.000849	0.012	CbGeAlD
Cytarabine—NT5E—decidua—uterine cancer	0.000835	0.0118	CbGeAlD
Cytarabine—NT5E—renal system—uterine cancer	0.00082	0.0116	CbGeAlD
Cytarabine—POLE—decidua—uterine cancer	0.000818	0.0115	CbGeAlD
Cytarabine—NT5E—endometrium—uterine cancer	0.000793	0.0112	CbGeAlD
Cytarabine—Gemcitabine—RRM2—uterine cancer	0.000791	0.217	CrCbGaD
Cytarabine—POLD1—female gonad—uterine cancer	0.000783	0.0111	CbGeAlD
Cytarabine—POLE—endometrium—uterine cancer	0.000777	0.011	CbGeAlD
Cytarabine—DCTD—female gonad—uterine cancer	0.000772	0.0109	CbGeAlD
Cytarabine—DCTD—vagina—uterine cancer	0.000768	0.0108	CbGeAlD
Cytarabine—NT5E—mammalian vulva—uterine cancer	0.000767	0.0108	CbGeAlD
Cytarabine—POLD1—Danazol—Progesterone—uterine cancer	0.000756	0.349	CbGdCrCtD
Cytarabine—POLE—mammalian vulva—uterine cancer	0.000751	0.0106	CbGeAlD
Cytarabine—POLA1—uterine cervix—uterine cancer	0.00074	0.0104	CbGeAlD
Cytarabine—NT5E—uterus—uterine cancer	0.00073	0.0103	CbGeAlD
Cytarabine—POLA1—decidua—uterine cancer	0.000705	0.00995	CbGeAlD
Cytarabine—CDA—vagina—uterine cancer	0.000698	0.00986	CbGeAlD
Cytarabine—POLA1—endometrium—uterine cancer	0.000669	0.00945	CbGeAlD
Cytarabine—NT5E—female reproductive system—uterine cancer	0.000657	0.00927	CbGeAlD
Cytarabine—POLA1—mammalian vulva—uterine cancer	0.000647	0.00914	CbGeAlD
Cytarabine—POLE—female reproductive system—uterine cancer	0.000643	0.00908	CbGeAlD
Cytarabine—POLB—lymph node—uterine cancer	0.000616	0.0087	CbGeAlD
Cytarabine—SLC29A1—myometrium—uterine cancer	0.000614	0.00866	CbGeAlD
Cytarabine—NT5E—female gonad—uterine cancer	0.000598	0.00843	CbGeAlD
Cytarabine—NT5E—vagina—uterine cancer	0.000594	0.00838	CbGeAlD
Cytarabine—DCK—myometrium—uterine cancer	0.000586	0.00828	CbGeAlD
Cytarabine—POLE—female gonad—uterine cancer	0.000585	0.00826	CbGeAlD
Cytarabine—POLE—vagina—uterine cancer	0.000582	0.00821	CbGeAlD
Cytarabine—ABCC10—myometrium—uterine cancer	0.000559	0.00788	CbGeAlD
Cytarabine—SLC22A2—renal system—uterine cancer	0.000515	0.00727	CbGeAlD
Cytarabine—POLA1—female gonad—uterine cancer	0.000505	0.00712	CbGeAlD
Cytarabine—POLD1—lymph node—uterine cancer	0.000503	0.0071	CbGeAlD
Cytarabine—POLA1—vagina—uterine cancer	0.000501	0.00708	CbGeAlD
Cytarabine—DCTD—lymph node—uterine cancer	0.000497	0.00701	CbGeAlD
Cytarabine—SLC29A1—uterine cervix—uterine cancer	0.000478	0.00674	CbGeAlD
Cytarabine—POLA1—Norethindrone—Progesterone—uterine cancer	0.000467	0.216	CbGdCrCtD
Cytarabine—DCK—uterine cervix—uterine cancer	0.000456	0.00644	CbGeAlD
Cytarabine—SLC29A1—decidua—uterine cancer	0.000455	0.00642	CbGeAlD
Cytarabine—CDA—lymph node—uterine cancer	0.000452	0.00638	CbGeAlD
Cytarabine—SLC29A1—renal system—uterine cancer	0.000447	0.00631	CbGeAlD
Cytarabine—DCK—decidua—uterine cancer	0.000435	0.00614	CbGeAlD
Cytarabine—ABCC10—uterine cervix—uterine cancer	0.000435	0.00614	CbGeAlD
Cytarabine—SLC29A1—endometrium—uterine cancer	0.000432	0.0061	CbGeAlD
Cytarabine—SLC29A1—mammalian vulva—uterine cancer	0.000418	0.0059	CbGeAlD
Cytarabine—ABCC10—decidua—uterine cancer	0.000414	0.00585	CbGeAlD
Cytarabine—DCK—endometrium—uterine cancer	0.000413	0.00582	CbGeAlD
Cytarabine—ABCC10—renal system—uterine cancer	0.000407	0.00574	CbGeAlD
Cytarabine—DCK—mammalian vulva—uterine cancer	0.000399	0.00563	CbGeAlD
Cytarabine—SLC29A1—uterus—uterine cancer	0.000398	0.00562	CbGeAlD
Cytarabine—ABCC10—endometrium—uterine cancer	0.000393	0.00555	CbGeAlD
Cytarabine—NT5E—lymph node—uterine cancer	0.000384	0.00542	CbGeAlD
Cytarabine—ABCC10—mammalian vulva—uterine cancer	0.00038	0.00537	CbGeAlD
Cytarabine—DCK—uterus—uterine cancer	0.00038	0.00537	CbGeAlD
Cytarabine—POLE—lymph node—uterine cancer	0.000376	0.00531	CbGeAlD
Cytarabine—POLA1—Levonorgestrel—Progesterone—uterine cancer	0.000371	0.172	CbGdCrCtD
Cytarabine—SLC22A1—renal system—uterine cancer	0.000364	0.00514	CbGeAlD
Cytarabine—ABCC10—uterus—uterine cancer	0.000362	0.00511	CbGeAlD
Cytarabine—SLC29A1—female reproductive system—uterine cancer	0.000358	0.00505	CbGeAlD
Cytarabine—DCK—female reproductive system—uterine cancer	0.000342	0.00482	CbGeAlD
Cytarabine—ABCC10—female reproductive system—uterine cancer	0.000326	0.0046	CbGeAlD
Cytarabine—SLC29A1—female gonad—uterine cancer	0.000326	0.0046	CbGeAlD
Cytarabine—POLA1—lymph node—uterine cancer	0.000324	0.00458	CbGeAlD
Cytarabine—SLC29A1—vagina—uterine cancer	0.000324	0.00457	CbGeAlD
Cytarabine—DCK—female gonad—uterine cancer	0.000311	0.00439	CbGeAlD
Cytarabine—DCK—vagina—uterine cancer	0.000309	0.00436	CbGeAlD
Cytarabine—ABCC10—female gonad—uterine cancer	0.000296	0.00418	CbGeAlD
Cytarabine—ABCC10—vagina—uterine cancer	0.000295	0.00416	CbGeAlD
Cytarabine—SLC22A1—vagina—uterine cancer	0.000264	0.00372	CbGeAlD
Cytarabine—DCK—Doxorubicin—Epirubicin—uterine cancer	0.000216	0.1	CbGdCrCtD
Cytarabine—SLC29A1—lymph node—uterine cancer	0.000209	0.00295	CbGeAlD
Cytarabine—DCK—Epirubicin—Doxorubicin—uterine cancer	0.0002	0.0925	CbGdCrCtD
Cytarabine—DCK—lymph node—uterine cancer	0.0002	0.00282	CbGeAlD
Cytarabine—ABCC10—lymph node—uterine cancer	0.000191	0.00269	CbGeAlD
Cytarabine—CYP3A4—renal system—uterine cancer	0.000166	0.00234	CbGeAlD
Cytarabine—DCK—Levonorgestrel—Progesterone—uterine cancer	0.000153	0.0707	CbGdCrCtD
Cytarabine—CYP3A4—female reproductive system—uterine cancer	0.000133	0.00188	CbGeAlD
Cytarabine—POLA1—Mitotic M-M/G1 phases—NDC80—uterine cancer	9.82e-05	0.00111	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—NDC80—uterine cancer	9.54e-05	0.00108	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—MLH3—uterine cancer	9.39e-05	0.00106	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—NDC80—uterine cancer	9.22e-05	0.00104	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—RRM2—uterine cancer	8.92e-05	0.00101	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—POLD1—uterine cancer	8.76e-05	0.00099	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—DCN—uterine cancer	8.66e-05	0.000978	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—CDKN1B—uterine cancer	8.65e-05	0.000977	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	8.6e-05	0.000971	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—CDKN2B—uterine cancer	8.56e-05	0.000967	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1B—uterine cancer	8.42e-05	0.000951	CbGpPWpGaD
Cytarabine—POLD1—Synthesis of DNA—CDKN1B—uterine cancer	8.28e-05	0.000935	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—CYP11A1—uterine cancer	8.16e-05	0.000921	CbGpPWpGaD
Cytarabine—POLA1—E2F transcription factor network—CDKN2A—uterine cancer	8.01e-05	0.000904	CbGpPWpGaD
Cytarabine—POLE—Synthesis of DNA—CDKN1B—uterine cancer	7.99e-05	0.000903	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	7.97e-05	0.0009	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—POLD1—uterine cancer	7.84e-05	0.000885	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—AKR1B1—uterine cancer	7.83e-05	0.000884	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—STAR—uterine cancer	7.83e-05	0.000884	CbGpPWpGaD
Cytarabine—POLD1—DNA Replication—CDKN1B—uterine cancer	7.76e-05	0.000877	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—AKR1C3—uterine cancer	7.7e-05	0.00087	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—RRM2—uterine cancer	7.56e-05	0.000854	CbGpPWpGaD
Cytarabine—POLE—DNA Replication—CDKN1B—uterine cancer	7.5e-05	0.000847	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—NDC80—uterine cancer	7.34e-05	0.000829	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—RRM2—uterine cancer	7.31e-05	0.000825	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	7.24e-05	0.000817	CbGpPWpGaD
Cytarabine—POLE—G1/S Transition—CDKN1B—uterine cancer	7.22e-05	0.000816	CbGpPWpGaD
Cytarabine—CDA—Metabolism—AKR1B1—uterine cancer	7.16e-05	0.000809	CbGpPWpGaD
Cytarabine—CDA—Metabolism—STAR—uterine cancer	7.16e-05	0.000809	CbGpPWpGaD
Cytarabine—POLA1—E2F transcription factor network—CDKN1B—uterine cancer	7.09e-05	0.000801	CbGpPWpGaD
Cytarabine—POLE—Mitotic G1-G1/S phases—CDKN2A—uterine cancer	6.87e-05	0.000776	CbGpPWpGaD
Cytarabine—POLD1—S Phase—CDKN1B—uterine cancer	6.79e-05	0.000767	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—RRM2—uterine cancer	6.76e-05	0.000764	CbGpPWpGaD
Cytarabine—POLE—G1 to S cell cycle control—TP53—uterine cancer	6.62e-05	0.000748	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—ABCC9—uterine cancer	6.57e-05	0.000742	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—NDC80—uterine cancer	6.57e-05	0.000742	CbGpPWpGaD
Cytarabine—POLE—S Phase—CDKN1B—uterine cancer	6.56e-05	0.00074	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—RRM2—uterine cancer	6.53e-05	0.000738	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	6.49e-05	0.000733	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—POLD1—uterine cancer	6.24e-05	0.000705	CbGpPWpGaD
Cytarabine—POLA1—E2F transcription factor network—EP300—uterine cancer	6.23e-05	0.000703	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1B—uterine cancer	6.16e-05	0.000696	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—POLD1—uterine cancer	6.14e-05	0.000694	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—NDUFB11—uterine cancer	6.14e-05	0.000694	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—SRD5A2—uterine cancer	6.14e-05	0.000694	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—ABCC9—uterine cancer	6.12e-05	0.000691	CbGpPWpGaD
Cytarabine—POLE—Mitotic G1-G1/S phases—CDKN1B—uterine cancer	6.09e-05	0.000687	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—YWHAE—uterine cancer	6.07e-05	0.000686	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—MLH1—uterine cancer	6.01e-05	0.000678	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—CYP19A1—uterine cancer	6e-05	0.000678	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—STK11—uterine cancer	6e-05	0.000678	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—YWHAE—uterine cancer	5.87e-05	0.000663	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—MLH1—uterine cancer	5.8e-05	0.000655	CbGpPWpGaD
Cytarabine—DCK—Metabolism—SRD5A2—uterine cancer	5.78e-05	0.000652	CbGpPWpGaD
Cytarabine—DCK—Metabolism—NDUFB11—uterine cancer	5.78e-05	0.000652	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—AKR1C1—uterine cancer	5.75e-05	0.000649	CbGpPWpGaD
Cytarabine—POLA1—Synthesis of DNA—CDKN1B—uterine cancer	5.7e-05	0.000643	CbGpPWpGaD
Cytarabine—CDA—Metabolism—POLD1—uterine cancer	5.62e-05	0.000635	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—POLD1—uterine cancer	5.58e-05	0.000631	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—TP53—uterine cancer	5.44e-05	0.000614	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—YWHAE—uterine cancer	5.43e-05	0.000613	CbGpPWpGaD
Cytarabine—POLA1—DNA Replication—CDKN1B—uterine cancer	5.34e-05	0.000603	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—uterine cancer	5.29e-05	0.000598	CbGpPWpGaD
Cytarabine—CDA—Metabolism—AKR1C1—uterine cancer	5.26e-05	0.000594	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—YWHAE—uterine cancer	5.25e-05	0.000592	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—RRM2—uterine cancer	5.21e-05	0.000588	CbGpPWpGaD
Cytarabine—POLA1—G1/S Transition—CDKN1B—uterine cancer	5.15e-05	0.000581	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—RRM2—uterine cancer	5.12e-05	0.000579	CbGpPWpGaD
Cytarabine—POLE—Mitotic M-M/G1 phases—BIRC5—uterine cancer	5.08e-05	0.000574	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—DCN—uterine cancer	4.97e-05	0.000562	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—uterine cancer	4.9e-05	0.000553	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	4.83e-05	0.000546	CbGpPWpGaD
Cytarabine—CDA—Metabolism—RRM2—uterine cancer	4.68e-05	0.000529	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—CYP11A1—uterine cancer	4.68e-05	0.000529	CbGpPWpGaD
Cytarabine—POLA1—S Phase—CDKN1B—uterine cancer	4.67e-05	0.000528	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—RRM2—uterine cancer	4.65e-05	0.000526	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—CDKN2B—uterine cancer	4.56e-05	0.000515	CbGpPWpGaD
Cytarabine—CDA—Metabolism—DCN—uterine cancer	4.55e-05	0.000514	CbGpPWpGaD
Cytarabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	4.52e-05	0.000511	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—MTHFR—uterine cancer	4.51e-05	0.000509	CbGpPWpGaD
Cytarabine—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	4.46e-05	0.000504	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—STAR—uterine cancer	4.44e-05	0.000502	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—AKR1B1—uterine cancer	4.44e-05	0.000502	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—AKR1C3—uterine cancer	4.42e-05	0.0005	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—CDKN2B—uterine cancer	4.41e-05	0.000498	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—CDKN1B—uterine cancer	4.34e-05	0.00049	CbGpPWpGaD
Cytarabine—CDA—Metabolism—CYP11A1—uterine cancer	4.28e-05	0.000484	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—YWHAE—uterine cancer	4.18e-05	0.000472	CbGpPWpGaD
Cytarabine—DCK—Metabolism—AKR1B1—uterine cancer	4.18e-05	0.000472	CbGpPWpGaD
Cytarabine—DCK—Metabolism—STAR—uterine cancer	4.18e-05	0.000472	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—MLH1—uterine cancer	4.13e-05	0.000467	CbGpPWpGaD
Cytarabine—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	4.12e-05	0.000465	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—CDKN2B—uterine cancer	4.08e-05	0.000461	CbGpPWpGaD
Cytarabine—CDA—Metabolism—AKR1C3—uterine cancer	4.05e-05	0.000457	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—CDKN2B—uterine cancer	3.94e-05	0.000445	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—BIRC5—uterine cancer	3.94e-05	0.000445	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—uterine cancer	3.87e-05	0.000437	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—BIRC5—uterine cancer	3.8e-05	0.00043	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—YWHAE—uterine cancer	3.74e-05	0.000422	CbGpPWpGaD
Cytarabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	3.67e-05	0.000414	CbGpPWpGaD
Cytarabine—POLA1—Mitotic M-M/G1 phases—BIRC5—uterine cancer	3.62e-05	0.000409	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	3.55e-05	0.000401	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—ABCC9—uterine cancer	3.53e-05	0.000399	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—BIRC5—uterine cancer	3.52e-05	0.000398	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	3.45e-05	0.00039	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—CYP19A1—uterine cancer	3.45e-05	0.000389	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—STK11—uterine cancer	3.45e-05	0.000389	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—BIRC5—uterine cancer	3.4e-05	0.000384	CbGpPWpGaD
Cytarabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	3.33e-05	0.000376	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—ABCC9—uterine cancer	3.29e-05	0.000372	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	3.29e-05	0.000371	CbGpPWpGaD
Cytarabine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	3.28e-05	0.000371	CbGpPWpGaD
Cytarabine—DCK—Metabolism—POLD1—uterine cancer	3.28e-05	0.00037	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—AKR1C1—uterine cancer	3.26e-05	0.000368	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	3.21e-05	0.000363	CbGpPWpGaD
Cytarabine—CDA—Metabolism—STK11—uterine cancer	3.15e-05	0.000356	CbGpPWpGaD
Cytarabine—CDA—Metabolism—CYP19A1—uterine cancer	3.15e-05	0.000356	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—CDKN2B—uterine cancer	3.14e-05	0.000355	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	3.1e-05	0.000351	CbGpPWpGaD
Cytarabine—DCK—Metabolism—AKR1C1—uterine cancer	3.07e-05	0.000346	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	3.02e-05	0.000342	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—RRM2—uterine cancer	2.91e-05	0.000328	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	2.88e-05	0.000326	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—DCN—uterine cancer	2.82e-05	0.000319	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CDKN2B—uterine cancer	2.81e-05	0.000317	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	2.73e-05	0.000309	CbGpPWpGaD
Cytarabine—DCK—Metabolism—RRM2—uterine cancer	2.73e-05	0.000309	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—BIRC5—uterine cancer	2.71e-05	0.000306	CbGpPWpGaD
Cytarabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	2.7e-05	0.000305	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—CYP11A1—uterine cancer	2.66e-05	0.0003	CbGpPWpGaD
Cytarabine—DCK—Metabolism—DCN—uterine cancer	2.65e-05	0.0003	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—CDKN2A—uterine cancer	2.61e-05	0.000295	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—MTHFR—uterine cancer	2.59e-05	0.000293	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—CDKN2A—uterine cancer	2.52e-05	0.000285	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—AKR1C3—uterine cancer	2.51e-05	0.000283	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PTEN—uterine cancer	2.51e-05	0.000283	CbGpPWpGaD
Cytarabine—DCK—Metabolism—CYP11A1—uterine cancer	2.5e-05	0.000282	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—BIRC5—uterine cancer	2.42e-05	0.000274	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—EP300—uterine cancer	2.39e-05	0.00027	CbGpPWpGaD
Cytarabine—CDA—Metabolism—MTHFR—uterine cancer	2.37e-05	0.000268	CbGpPWpGaD
Cytarabine—DCK—Metabolism—AKR1C3—uterine cancer	2.36e-05	0.000267	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	2.36e-05	0.000266	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—CDKN2A—uterine cancer	2.33e-05	0.000264	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	2.32e-05	0.000262	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—CDKN1B—uterine cancer	2.31e-05	0.000261	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—NDUFB11—uterine cancer	2.29e-05	0.000258	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—SRD5A2—uterine cancer	2.29e-05	0.000258	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—CDKN2A—uterine cancer	2.25e-05	0.000255	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—CDKN1B—uterine cancer	2.23e-05	0.000252	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	2.13e-05	0.000241	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—NDUFB11—uterine cancer	2.13e-05	0.000241	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—SRD5A2—uterine cancer	2.13e-05	0.000241	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	2.07e-05	0.000234	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—CDKN1B—uterine cancer	2.07e-05	0.000233	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	2.06e-05	0.000233	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—EP300—uterine cancer	2.03e-05	0.000229	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—CDKN1B—uterine cancer	2e-05	0.000225	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—EP300—uterine cancer	1.96e-05	0.000221	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—CYP19A1—uterine cancer	1.96e-05	0.000221	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—STK11—uterine cancer	1.96e-05	0.000221	CbGpPWpGaD
Cytarabine—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	1.95e-05	0.00022	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	1.92e-05	0.000217	CbGpPWpGaD
Cytarabine—DCK—Metabolism—STK11—uterine cancer	1.84e-05	0.000208	CbGpPWpGaD
Cytarabine—DCK—Metabolism—CYP19A1—uterine cancer	1.84e-05	0.000208	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—EP300—uterine cancer	1.81e-05	0.000205	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	1.81e-05	0.000205	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—CDKN2A—uterine cancer	1.8e-05	0.000203	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PIK3CA—uterine cancer	1.77e-05	0.0002	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—EP300—uterine cancer	1.75e-05	0.000198	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.74e-05	0.000197	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—AKR1B1—uterine cancer	1.65e-05	0.000187	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—STAR—uterine cancer	1.65e-05	0.000187	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CDKN2A—uterine cancer	1.61e-05	0.000181	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—CDKN1B—uterine cancer	1.59e-05	0.00018	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—STAR—uterine cancer	1.54e-05	0.000174	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—AKR1B1—uterine cancer	1.54e-05	0.000174	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—MTHFR—uterine cancer	1.47e-05	0.000166	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—AKT1—uterine cancer	1.45e-05	0.000163	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PTEN—uterine cancer	1.44e-05	0.000163	CbGpPWpGaD
Cytarabine—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	1.43e-05	0.000162	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CDKN1B—uterine cancer	1.42e-05	0.000161	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	1.41e-05	0.00016	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—EP300—uterine cancer	1.4e-05	0.000158	CbGpPWpGaD
Cytarabine—DCK—Metabolism—MTHFR—uterine cancer	1.38e-05	0.000156	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—EP300—uterine cancer	1.37e-05	0.000155	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PTEN—uterine cancer	1.32e-05	0.000149	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—TP53—uterine cancer	1.3e-05	0.000147	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—POLD1—uterine cancer	1.3e-05	0.000147	CbGpPWpGaD
Cytarabine—CDA—Metabolism—EP300—uterine cancer	1.26e-05	0.000142	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—TP53—uterine cancer	1.25e-05	0.000142	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—EP300—uterine cancer	1.25e-05	0.000141	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—AKR1C1—uterine cancer	1.21e-05	0.000137	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—POLD1—uterine cancer	1.21e-05	0.000137	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—AKR1C1—uterine cancer	1.13e-05	0.000128	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—RRM2—uterine cancer	1.08e-05	0.000122	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—DCN—uterine cancer	1.05e-05	0.000119	CbGpPWpGaD
Cytarabine—SLC22A2—Transmission across Chemical Synapses—HRAS—uterine cancer	1.03e-05	0.000116	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PIK3CA—uterine cancer	1.02e-05	0.000115	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—RRM2—uterine cancer	1.01e-05	0.000114	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—CYP11A1—uterine cancer	9.9e-06	0.000112	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—DCN—uterine cancer	9.79e-06	0.000111	CbGpPWpGaD
Cytarabine—SLC22A1—Transmission across Chemical Synapses—HRAS—uterine cancer	9.6e-06	0.000108	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—AKR1C3—uterine cancer	9.35e-06	0.000106	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PIK3CA—uterine cancer	9.3e-06	0.000105	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—CYP11A1—uterine cancer	9.22e-06	0.000104	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—TP53—uterine cancer	8.94e-06	0.000101	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—AKR1C3—uterine cancer	8.71e-06	9.84e-05	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—AKT1—uterine cancer	8.3e-06	9.38e-05	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PTEN—uterine cancer	8.17e-06	9.23e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—HRAS—uterine cancer	7.89e-06	8.91e-05	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—EP300—uterine cancer	7.8e-06	8.8e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—NDUFB11—uterine cancer	7.7e-06	8.7e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—SRD5A2—uterine cancer	7.7e-06	8.7e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PTEN—uterine cancer	7.69e-06	8.68e-05	CbGpPWpGaD
Cytarabine—CDA—Metabolism—AKT1—uterine cancer	7.59e-06	8.58e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—HRAS—uterine cancer	7.35e-06	8.31e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—EP300—uterine cancer	7.33e-06	8.28e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—STK11—uterine cancer	7.28e-06	8.22e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—CYP19A1—uterine cancer	7.28e-06	8.22e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—STK11—uterine cancer	6.79e-06	7.67e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—CYP19A1—uterine cancer	6.79e-06	7.67e-05	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PIK3CA—uterine cancer	5.77e-06	6.51e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—AKR1B1—uterine cancer	5.57e-06	6.29e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—STAR—uterine cancer	5.57e-06	6.29e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—MTHFR—uterine cancer	5.47e-06	6.18e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PIK3CA—uterine cancer	5.42e-06	6.12e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—MTHFR—uterine cancer	5.1e-06	5.76e-05	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—AKT1—uterine cancer	4.71e-06	5.32e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—AKT1—uterine cancer	4.43e-06	5e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—POLD1—uterine cancer	4.37e-06	4.93e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—AKR1C1—uterine cancer	4.09e-06	4.62e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—RRM2—uterine cancer	3.64e-06	4.11e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—DCN—uterine cancer	3.54e-06	3.99e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—CYP11A1—uterine cancer	3.33e-06	3.76e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—AKR1C3—uterine cancer	3.15e-06	3.55e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PTEN—uterine cancer	3.04e-06	3.44e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—EP300—uterine cancer	2.9e-06	3.28e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PTEN—uterine cancer	2.84e-06	3.2e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—EP300—uterine cancer	2.71e-06	3.06e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—STK11—uterine cancer	2.45e-06	2.77e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—CYP19A1—uterine cancer	2.45e-06	2.77e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PIK3CA—uterine cancer	2.15e-06	2.43e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PIK3CA—uterine cancer	2e-06	2.26e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—MTHFR—uterine cancer	1.84e-06	2.08e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—AKT1—uterine cancer	1.75e-06	1.98e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—AKT1—uterine cancer	1.64e-06	1.85e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PTEN—uterine cancer	1.02e-06	1.16e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—EP300—uterine cancer	9.77e-07	1.1e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PIK3CA—uterine cancer	7.23e-07	8.16e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—AKT1—uterine cancer	5.9e-07	6.67e-06	CbGpPWpGaD
